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pT o offer a German perspective on reimburse-ment and its impact on cardiology practice,key features of the current system in Ger-
any are presented.
Changes in the way cardiology is practiced and
eimbursed in the United States—real and anticipat-
d—have created frustrations and concerns among
merican cardiologists. Therefore it might be infor-
ative to look at other developed healthcare and re-
mbursement systems. In this paper, the authors in-
end to provide a concise although necessarily
ncomplete overview of the reimbursement system in
ardiology in Germany and how it has affected cardi-
logy practice.
erman Cardiology Healthcare
erman cardiology, in several respects, provides for
n interesting comparison with its U.S. counterpart.
any characteristics are similar. There are no sub-
tantial waiting lists for medical procedures (except
on-economically caused waiting lists [e.g., for heart
ransplants]), and there is no rationing. To illustrate
he level of cardiology care serving the German popu-
ation of 82 million inhabitants, who on average are
onsiderably older than their American counterparts
percentage of population over 60 years old, 26% vs.
8%, respectively) (1,2), the following numbers in-
exed to 1 million inhabitants might be considered
latest available figures, all 2006 or later):
Cardiologists (3,4): Germany 49; United
States 85
Coronary angiograms (3,5) Germany 10,573;
United States 3,742 (inpatients only)
Percutaneous coronary interventions (PCIs)
(3,5): Germany 3,792; United States 4,406
(inpatients only)
Coronary bypass surgery (5,6): Germany 715;
United States 1,503 rFor 2008 total healthcare costs were estimated at
0.5% of the German gross domestic income—
igher than, for example, in Great Britain (8.7%)
ut substantially lower than in the United States
16%) (7).
Importantly, the healthcare system, including car-
iology, is consistently rated overall as adequate and
fficient by the German public.
Health care in Germany is financed by a mixed
ystem of “statutory” (Gesetzliche Krankenkassen)
nd private insurances, which cover very nearly the
hole population. The statutory insurances are the
efault option insuring the vast majority of individu-
ls (approximately 90%). The statutory insurance fee
s a fixed percentage of the salary (currently 15.5%),
ne-half of which is paid for by the beneficiary, and
ne-half is paid for by the employer. Unemployed
ndividuals are insured in a statutory insurance at the
xpense of the state. Statutory insurances also cover
he family of the employee at no extra cost. All major
ealth costs, including drugs, are paid for, except for
mall additional fees (e.g., for each outpatient visit,
nd a per-day fee for hospital stays). Approximately
0% of the population is privately insured; this op-
ion can only be chosen by salaried individuals above
certain income level or by state employees. Private
nsurance fees depend on the extent of services insured
e.g., dental work), co-payments, amenities like sin-
le- or double-room hospital accommodation, in-
ospital treatment by the chief of the department, and
thers. Family members are insured at extra cost in
rivate insurance.
Most hospitals are publicly owned or owned by
onprofit organizations; these hospitals finance their
osts of operation, including salaries of healthcare
ersonnel, material costs and the like from case-based
eimbursement of healthcare services by the insurers;
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to construction, are publicly financed (i.e., from taxes).
One-third of all hospitals are privately owned and also re-
ceive reimbursement for operational costs from health in-
surances as the former group of hospitals. Cardiology out-
patient care is mainly delivered by cardiologists and
internists in private practice.
Reimbursement: Inpatients
For hospitals, reimbursement is determined by a diagnosis-
related groups (DRG) or “flat fee” principle: the docu-
mented final diagnosis together with other factors like co-
morbidities and length of hospital stay determine the
amount of money that the insurance reimburses to the hos-
pital/admission. This holds for both statutory and private
insurance; the latter reimburses additionally in a fee-for-
service manner personal treatment by specific hospital phy-
sicians—usually the department chiefs—and certain ame-
nities like better accommodation, making it desirable for
hospitals to attract privately insured patients.
Although the principle of a flat fee for a given diagnosis
should financially discourage extensive use of resources, proce-
dures play a powerful role in the German reimbursement sys-
tem, because they modify the final diagnosis code. For a better
understanding, consider the following schematic scenarios
Approximate Reimbursement for Cardiologic Exams and ProceduTable 1 Approximate Reimbursement for Cardiologic Exams
Treatment Setting
Outpatient
Statutory Insurance Private I
Physical examination No extra reimbursement beyond
outpatient fee
$55 (€
ECG No extra reimbursement beyond
outpatient fee
$38 (€
Transthoracic echo No extra reimbursement beyond
outpatient fee
$267 (€
Stress echo No extra reimbursement beyond
outpatient fee
$375 (€
Cardiac CT/noninvasive
coronary angiography
No extra reimbursement beyond
outpatient fee
$1,177 (€
Invasive coronary
angiography
Beyond outpatient fee, a fixed
sum of $388 (€277) for
consumable material and
post-angiography monitoring
reimbursement
$2,058 (€
Coronary angiography 
ad hoc percutaneous
intervention (1 drug-
eluting stent in 1 vessel)
Unusual in outpatient setting unusual in
setting
Numbers vary by location, insurance, and specific insurance program; values in dollars are base
thus might be higher. Outpatient fee: $84 every 3 months.
CT  computed tomography; DRG  diagnosis-related group; ECG  electrocardiogram.involving patients admitted to a hospital due to acute chest
pain, in whom an acute myocardial infarction is initially ruled
out (Table 1). Statutory insurance is assumed. All cited sums
are approximative and vary considerably, depending on loca-
tion, insurance company involved, capped volumes, and other
details; a 1:1.4 exchange rate €/$ was assumed:
. In Patient A an exercise electrocardiogram (ECG) and an
echo are performed, which are unremarkable, and the
patient is released on Day 2. The typical DRG-based
reimbursement is $832 (€594).
. Patient B on the second day undergoes coronary angiogra-
phy. Diffuse coronary artery disease is seen without a lesion
deemed suitable for intervention. He is released home on
Day 3. Although the coronary angiography as such is not
reimbursed, it serves as a justification for an additional hos-
pital day, bringing the typical reimbursement to $2,100
(€1,500).
. Patient C also undergoes coronary angiography. A coro-
nary stenosis is seen, and an intervention is performed
with implantation of a drug-eluting stent (cost of stent:
approximately $800); the patient is released on Day 3.
The typical DRG-based reimbursement, including stent
costs, is $4,712 (€3,366).
n Germanyrocedures in Germany
ce
Inpatient
Statutory Insurance Private Insurance
No extra reimbursement beyond
DRG fee for main diagnosis
$42 (€30) additional to DRG fee
for main diagnosis
No extra reimbursement beyond
DRG fee for main diagnosis
$28 (€20) additional to DRG fee
for main diagnosis
No extra reimbursement beyond
DRG fee for main diagnosis
$201 (€143) additional to DRG
fee for main diagnosis
No extra reimbursement beyond
DRG fee
$281 (€201) additional to DRG
fee for main diagnosis
No extra reimbursement beyond
DRG fee for main diagnosis
$883 (€631) additional to DRG
fee for main diagnosis
No extra reimbursement beyond
DRG fee for main diagnosis
(see example in text)
$1,544 (€1,103) additional to
DRG fee for main diagnosis
tient $4,712 (€3,366), corresponding
to DRG fee  stent cost
$2,940 (€2,100) additional to
DRG fee  stent cost of
$4,712 (€3,366)
1:1.4 exchange rate. Note that for private patients, reimbursement is basically negotiable andres iand P
nsuran
39)
27)
191)
268)
841)
1,470)
outpa
d on a
12
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For outpatients, the statutory insurances pay a very low flat fee/
patient/quarter of the year, currently approximately $84, as long
as at least an echo is performed in addition to physical examina-
tion and ECG, regardless of additional ambulatory tests or treat-
ments. For private outpatients, however, the cardiologist can
charge on a fee-for-service basis. To illustrate this, again 3 sche-
matic outpatient statutory insurance scenarios for patients with
chronic chest pain are outlined (Table 1):
. In Patient A, a physical and laboratory examination, a resting
ECG, an echocardiogram, and an exercise test are per-
formed. The typical reimbursement for a patient with statu-
tory insurance is the previously cited flat sum, approximately
$84, paid once/patient/quarter of the year, regardless of the
number of visits. If the patient has private insurance, these 4
examinations can be billed individually.
. In Patient B, an additional stress echo is performed. A new
wall motion abnormality is seen at peak bicycle exercise, and
the patient is scheduled for an outpatient coronary angiog-
raphy. The latter reveals no critical lesions. For an outpatient
with statutory insurance, beyond the flat fee there is no
additional reimbursement for the stress echo; for the coro-
nary angiography, material costs and post-procedure moni-
Figure 1 Increase in Cardiac Catheterization From 1980 to 2
Yearly rates of left heart catheterization (including coronary angiography) and p
the x-axis. PCI procedures involving several lesions in 1 session were countedtoring are compensated by a fixed sum of approximately
$388 (€277). If the patient is privately insured, both stress
echo and the coronary angiography are reimbursed, the latter
considerably higher.
3. In Patient C, workup is as for patient B, but on angiography
a coronary stenosis is seen. A PCI is performed with implan-
tation of a drug-eluting stent, and the patient is admitted for
1 night to a hospital, bringing reimbursement for patients in
statutory insurance to approximately $3,571 (€2,551) and
considerably higher if the patient is privately insured.
Commentary
As these schematic examples show, the reimbursement sys-
tem inordinately favors performing procedures such as PCI,
whereas conservative (and preventive) efforts in comparison
result in very low compensation. Not surprisingly, this has
affected and continues to affect the practice of cardiology.
Over the past 20 years, the number of catheterization labo-
ratories in Germany grew from 234 to 830, and procedure
rates rose dramatically (3): coronary angiography rates more
than quadrupled, and PCIs increased almost 10-fold
(Fig. 1). The resulting per-capita number of procedures by
far outstrip the corresponding figures in other European
in Germany
neous coronary intervention (PCI) (in 1000s) on the y-axis; calendar years on
Modified, with permission, from Bruckenberger (3).009
ercuta
as 1.
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dards (Fig. 2).
A particularly unfortunate consequence of the system is
that noninvasive tests such as stress tests or cardiac imaging,
both in-hospital or in the outpatient setting, do not gener-
ate any compensation from statutory insurance. Further-
more, if their consequence is conservative treatment, the
hospital or the practicing physician barely break even or
incur a financial loss.
It has been debated hotly whether there is deliberate
overuse of procedures for financial reasons in Germany
(9–11). This cannot be established on the basis of the avail-
able data. For example, a study analyzing appropriateness of
cardiovascular interventions in Germany in the years 2000
to 2001 found only 2% of PCI clearly inappropriate, al-
though 41% of PCI were deemed of uncertain appropriate-
Figure 2 Number of Coronary Angiograms and PCIs in Select
Numbers/million inhabitants, from 2006, on the y-axis. Percutaneous coronary
as 1. Germany has the highest rate of coronary angiograms and PCIs, together
angiography figures for United States refer only to inpatients (5). Modified, withness (12). Alternatively, some observers have suggested that
German cardiology might just be pioneering a more inva-
sive approach to coronary heart disease, with other Euro-
pean countries lagging behind for a variety of reasons
(10,13). The decreasing hospital mortality of myocardial
infarction and generally of ischemic heart disease in Ger-
many certainly suggest that the management of ischemic
heart disease has been successful overall. However, in com-
parison with European countries similar to Germany by age
structure, lifestyle, gross national product, and healthcare
system (e.g., the Netherlands), it is notable that:
● numbers of coronary angiographies and percutaneous in-
terventions/capita are much higher in Germany (Fig. 2);
● there is a clearly lower ratio of coronary interventions to
coronary angiograms in Germany (0.36 vs. 0.50 in the
Netherlands); and
uropean Countries
ention (PCI) procedures involving several lesions in 1 session were counted
he lowest ratio of PCIs to coronary angiograms (1:2.8). *PCI and coronary
ission from Europa Edition, from Moschovitis et al. (8).ed E
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April 24, 2012:1561–5 Cardiology Reimbursement in Germany● mortality from heart disease in the Netherlands is lower
than in Germany (standardized death rate, 43/100,000
inhabitants) than in Germany (standardized death rate,
43/100,000 inhabitants) (14).
The diagnosis-related group, “flat-fee” reimbursement
ystem might in theory enable better allocation of resources
han a fee-for-service principle. In the current German real-
zation of this idea, however, an originally perhaps reason-
ble bonus system for performing costly procedures has
ecome the financial driver of the system, in particular be-
ause of an unsustainably low level of reimbursement of
onservative management. Thus, although the past stun-
ing expansion of procedure numbers certainly is multifac-
orial, the present reimbursement rules are deeply dysfunc-
ional, in particular in light of current understanding of
roper management of coronary artery disease. The present
ules financially penalize conservative clinical management,
e-emphasize ischemia testing, and continue to encourage
nvasive procedures. These features need to be corrected to
lign the financial logic with medical reason.
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